Persistent sichert sich eine starke Mehrheitsbeteiligung

Persistent secured approximately 94.04% of Nagarro’s share capital and voting rights, including 8,903,259 shares tendered in its offer (about 71.94%) and a roughly 22.10% stake acquired from Lantano. The offer exceeded its 50%-plus-one-share minimum threshold. Persistent plans to initiate a squeeze-out of remaining minority shareholders after closing, but has made no final decision; completion is expected by the end of calendar Q1 2027, subject to a limited number of regulatory approvals.

Analysis

The offer outcome sharply lowers the probability of a failed acquisition, but it does not validate the promised AI-engineering and cross-selling thesis. The important value-transfer question is whether Persistent can retain Nagarro’s delivery talent and customers through integration; disruption could instead create openings for Infosys, HCLTech, and Tata Consultancy Services to compete for staff or client work. These are plausible spillovers, not evidence of current defections.

For Nagarro, the remaining path is chiefly regulatory completion and the treatment of minority holders, not a fresh operating catalyst. A squeeze-out could reduce liquidity and leave holdouts exposed to process and valuation uncertainty. For Persistent, the strategic upside is longer-dated, while integration demands and any acquisition funding burden arrive earlier; the release does not provide enough information to quantify either.

Near term, the completion timetable and remaining approvals drive event risk. Over 6–18 months, retention, organic growth, and evidence of cross-selling matter more than the deal announcement. The contrarian point: high shareholder acceptance is a transaction milestone, not independent evidence that synergies will exceed integration costs. No valuation or spread conclusion is supportable without the offer consideration, current prices, financing terms, and detailed squeeze-out process.

Key Decisions for Investors

• Nagarro: treat the position as event-driven rather than as an operating-growth thesis. Before trading the remaining spread, verify the offer price, settlement conditions, current market price, and applicable minority-holder process; do not assume a squeeze-out guarantees a particular premium or timing.
• Persistent: avoid chasing an announcement-driven move absent evidence on funding, integration costs, and post-close targets. Reassess after approval updates and the first disclosed retention, growth, or margin indicators for the combined business.
• Monitor the regulatory path through the expected close and flag any approval delay or change to transaction terms as a catalyst to reassess completion risk.
• Falsifiers for the strategic case include material customer or key-staff losses, weaker-than-expected combined-business guidance, or evidence that acquisition funding constrains Persistent’s investment or returns.